AlphaMadera
Hims & Hers Health, Inc. (HIMS)
$24.06
-2.60 (-9.75%)Delayed quote.
Price history
Daily close- Start
- $41.52
- Latest close
- $24.06
- Period change
- -42.05%
- Period low
- $14.52
- Period high
- $41.52
Key metrics
- Market cap
- $5.41B
- Volume
- 17.48M
- Average volume
- 11.89M
- 52-week range
- $13.74 – $44.00
- Beta
- 2.50
- Last dividend
- —
- EPS (TTM)
- -$0.61
- P/E ratio
- 56.96
- Revenue (TTM)
- $2.58B
- Net income (TTM)
- -$142.03M
- Total assets
- $3.63B
- Total debt
- $1.55B
- Cash and equivalents
- $609.81M
Key financials (trailing twelve months).
Company profile
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Exchange
- NYSE
- CEO
- Andrew Dudum
- Employees
- 2,442
- Headquarters
- San Francisco, CA, US
- IPO date
- 2019-09-13
- Website
- https://www.hims.com
Financial statements
Annual, last 3 fiscal years. Most recent period first. Reported in USD.
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Revenue | $2.35B | $1.48B | $872.00M |
| Gross profit | $1.73B | $1.17B | $714.95M |
| Operating income | $105.61M | $61.90M | -$29.45M |
| EBITDA | $178.43M | $88.80M | -$12.06M |
| Net income | $128.37M | $126.04M | -$23.55M |
| Diluted EPS | $0.51 | $0.53 | -$0.11 |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Cash and equivalents | $228.62M | $220.58M | $96.66M |
| Total assets | $2.15B | $707.54M | $441.19M |
| Total liabilities | $1.61B | $230.82M | $97.16M |
| Total debt | $1.12B | $11.35M | $9.95M |
| Shareholders’ equity | $540.93M | $476.72M | $344.03M |
| Metric | FY2025Dec 31, 2025 | FY2024Dec 31, 2024 | FY2023Dec 31, 2023 |
|---|---|---|---|
| Operating cash flow | $300.01M | $251.08M | $73.48M |
| Capital expenditure | -$226.04M | -$52.75M | -$26.49M |
| Free cash flow | $73.96M | $198.33M | $46.99M |
Quarterly, last 6 quarters. Most recent period first. Reported in USD.
| Metric | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | $753.21M | $608.10M | $617.82M | $598.98M | $544.83M | $586.01M |
| Gross profit | $480.80M | $300.28M | $444.44M | $442.06M | $416.20M | $430.69M |
| Operating income | -$97.19M | -$16.47M | $9.19M | $11.81M | $26.72M | $57.90M |
| EBITDA | -$63.16M | -$79.60M | $36.45M | $29.89M | $43.32M | $68.77M |
| Net income | -$86.29M | -$92.11M | $20.60M | $15.77M | $42.51M | $49.48M |
| Diluted EPS | -$0.37 | -$0.40 | $0.08 | $0.06 | $0.17 | $0.20 |
| Metric | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $609.81M | $222.27M | $228.62M | $345.78M | $1.12B | $273.74M |
| Total assets | $3.63B | $2.27B | $2.15B | $2.23B | $1.88B | $891.71M |
| Total liabilities | $3.30B | $1.82B | $1.61B | $1.65B | $1.31B | $342.45M |
| Total debt | $1.55B | $1.13B | $1.12B | $1.12B | $1.04B | $63.38M |
| Shareholders’ equity | $324.07M | $446.17M | $540.93M | $580.98M | $562.70M | $549.26M |
| Metric | Q2 2026Jun 30, 2026 | Q1 2026Mar 31, 2026 | Q4 2025Dec 31, 2025 | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$35.94M | $89.36M | $64.70M | $148.72M | -$19.12M | $109.09M |
| Capital expenditure | -$19.45M | -$36.32M | -$63.88M | -$57.30M | -$50.31M | -$59.04M |
| Free cash flow | -$55.38M | $53.03M | $821.0K | $91.42M | -$69.43M | $50.05M |